Prostate cancer: Review in 2014 - Abstract

Recent advances need to be highlighted in the management of both localized and metastatic prostate cancer.

New early detection and molecular characterization tools are being developed to improve differentiation of their progression profiles and reduce "overdetection" and "overtreatment" of clinically "insignificant" cancers. In addition, the development of multi-parametric MR has improved the characterization of localized cancer and introduced the new concept of focal treatment. Finally, several treatments for metastatic cancer which is resistant to castration have recently increased the therapeutic armamentarium.

Written by:
Barry Delongchamps N.   Are you the author?
Urology Department, Cochin Hospital, 27, rue du Faubourg Saint-Jacques, 75679 Paris cedex 14, France.  

Reference: Diagn Interv Imaging. 2014 Jul-Aug;95(7-8):739-42.
doi: 10.1016/j.diii.2014.06.005


PubMed Abstract
PMID: 25052225

UroToday.com Prostate Cancer Section

 

 

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe